Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis.

Akdemir G, Markusse IM, Bergstra SA, Goekoop RJ, Molenaar ET, van Groenendael JHLM, Kerstens PJSM, Lems WF, Huizinga TWJ, Allaart CF.

RMD Open. 2018 May 20;4(1):e000649. doi: 10.1136/rmdopen-2018-000649. eCollection 2018.

2.

TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.

Loef M, Kroon FPB, Bergstra SA, van der Pol JA, Lems WF, Kerstens PJSM, Allaart CF, Kloppenburg M.

Rheumatology (Oxford). 2018 Feb 19. doi: 10.1093/rheumatology/key016. [Epub ahead of print]

PMID:
29471377
3.

Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial.

Ter Wee MM, Coupé VM, den Uyl D, Blomjous BS, Kooijmans E, Kerstens PJ, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Boers M, Lems WF.

RMD Open. 2017 Oct 25;3(2):e000502. doi: 10.1136/rmdopen-2017-000502. eCollection 2017.

4.

Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.

Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, van der Wijden LKM, Bultink IEM, Kerstens PJSM, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Rheumatology (Oxford). 2017 Sep 1;56(9):1586-1596. doi: 10.1093/rheumatology/kex223.

PMID:
28859326
5.

Age affects joint space narrowing in patients with early active rheumatoid arthritis.

Matthijssen XM, Akdemir G, Markusse IM, Stijnen T, Riyazi N, Han KH, Bijkerk C, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

RMD Open. 2016 Oct 18;2(2):e000338. eCollection 2016.

6.

Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.

Akdemir G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, Grillet BA, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Clin Rheumatol. 2017 Feb;36(2):317-326. doi: 10.1007/s10067-016-3405-8. Epub 2016 Sep 28.

7.

Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial.

Markusse IM, Akdemir G, Dirven L, Goekoop-Ruiterman YP, van Groenendael JH, Han KH, Molenaar TH, Le Cessie S, Lems WF, van der Lubbe PA, Kerstens PJ, Peeters AJ, Ronday HK, de Sonnaville PB, Speyer I, Stijnen T, Ten Wolde S, Huizinga TW, Allaart CF.

Ann Intern Med. 2016 Apr 19;164(8):523-31. doi: 10.7326/M15-0919. Epub 2016 Mar 1.

PMID:
27089068
8.

Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis.

Bergstra SA, Markusse IM, Akdemir G, Ronday HK, Han KH, Lems WF, Kerstens PJSM, van den Berg R, Landewé RBM, Allaart CF.

Clin Rheumatol. 2016 Aug;35(8):2101-2107. doi: 10.1007/s10067-015-3145-1. Epub 2015 Dec 22.

9.

Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.

Markusse IM, Dirven L, Gerards AH, van Groenendael JH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2015 Aug 31;17:232. doi: 10.1186/s13075-015-0730-2.

10.

Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.

Markusse IM, Dirven L, Han KH, Ronday HK, de Sonnaville PB, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):446-53. doi: 10.1002/acr.22681.

11.

Continued participation in a ten-year tight control treat-to-target study in rheumatoid arthritis: why keep patients doing their best?

Markusse IM, Dirven L, Han KH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Care Res (Hoboken). 2015 May;67(6):739-45. doi: 10.1002/acr.22540.

12.

Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.

Markusse IM, de Vries-Bouwstra JK, Han KH, van der Lubbe PA, Schouffoer AA, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2014 Sep 25;16(5):430. doi: 10.1186/s13075-014-0430-3.

13.

A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.

Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han KH, Ronday HK, Bolce R, Sasso EH, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

J Rheumatol. 2014 Nov;41(11):2114-9. doi: 10.3899/jrheum.131412. Epub 2014 Aug 15.

14.

Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis.

van den Broek M, Dirven L, Kroon HM, Kloppenburg M, Ronday HK, Peeters AJ, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

J Rheumatol. 2013 May;40(5):624-9. doi: 10.3899/jrheum.121248. Epub 2013 Apr 1.

PMID:
23547212
15.

Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients.

Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1235-42. doi: 10.1002/acr.21978.

16.

Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy.

Dirven L, Klarenbeek NB, van den Broek M, van Groenendael JH, de Sonnaville PB, Kerstens PJ, Huizinga TW, Dijkmans BA, Lems WF, Allaart CF.

Clin Rheumatol. 2013 May;32(5):585-90. doi: 10.1007/s10067-012-2136-8. Epub 2012 Dec 9.

PMID:
23224330
17.

Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints.

Dirven L, van den Broek M, Kroon HM, Grillet BA, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

Rheumatology (Oxford). 2012 Dec;51(12):2262-8. doi: 10.1093/rheumatology/kes228. Epub 2012 Sep 1.

PMID:
22942403
18.

Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis.

Dirven L, van den Broek M, van Groenendael JH, de Beus WM, Kerstens PJ, Huizinga TW, Allaart CF, Lems WF.

BMC Musculoskelet Disord. 2012 Jul 23;13:125. doi: 10.1186/1471-2474-13-125.

19.

Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.

van den Broek M, Dirven L, de Vries-Bouwstra JK, Dehpoor AJ, Goekoop-Ruiterman YP, Gerards AH, Kerstens PJ, Huizinga TW, Lems W, Allaart CF.

Ann Rheum Dis. 2012 Sep;71(9):1530-3. doi: 10.1136/annrheumdis-2011-201212. Epub 2012 Apr 24.

PMID:
22532630
20.

Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies.

van der Woude D, Visser K, Klarenbeek NB, Ronday HK, Peeters AJ, Kerstens PJ, Dijkmans BA, Huizinga TW, van der Helm-van Mil AH, Allaart CF.

Rheumatology (Oxford). 2012 Jun;51(6):1120-8. doi: 10.1093/rheumatology/ker516. Epub 2012 Feb 15.

PMID:
22337939

Supplemental Content

Loading ...
Support Center